Clene Inc. Debt Securities, Available-for-sale
Clene Inc. (CLNN) had Debt Securities, Available-for-sale of $0 as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Investments
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2023-11-07
- 2023-06-30: Debt Securities, Available-for-sale $0.00.
- 2023-03-31: Debt Securities, Available-for-sale $0.00.
- 2022-12-31: Debt Securities, Available-for-sale $4.98M.
- 2022-09-30: Debt Securities, Available-for-sale $8.97M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 |
| 2022-12-31 | $4.98M 10-Q · filed 2023-11-07 |
| 2022-09-30 | $8.97M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $19.03M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $23.59M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |